Back

Stereotactic cardiac radioablation for refractory ventricular tachycardia - electrical properties and conduction velocity analysis

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Ventricular tachycardia ablation outcomes Ablation of Ventricular Arrhythmias EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Doctor Tomasz Jadczyk

Medical University of Silesia, Katowice (Poland)

6 More presentations in this session

Presentation thumbnail
Putting the PAINESD/PAAINESD scores to the test: a seven-year validation of risk prediction for hemodynamic decompensation during VT ablation
Doctor J. Dickow (Hamburg, DE)
Abstract Slides Video
Presentation thumbnail
Comparative efficacy of stereotactic body radiotherapy versus radiofrequency catheter ablation in refractory ventricular tachyarrhythmia: results from the vt-art consortium
Doctor M. Narducci (Rome, IT)
Abstract Slides Video
Presentation thumbnail
Unmasking the ring: substrate features and outcomes after ventricular tachycardia ablation in patients with ring-like late gadolinium enhancement pattern
Doctor R. Pittorru (Barcelona, ES)
Abstract Slides Video
Presentation thumbnail
Revisiting ventricular tachycardia ablation: insights into pulsed field energy. A systematic review and meta-analysis of prospective studies
Doctor A. Deaconu (Bucharest, RO)
Abstract Slides Video
Presentation thumbnail
Early catheter ablation in electrical storm: a propensity score-matched comparison with medical therapy
Doctor R. Carvalho (Lisbon, PT)
Abstract Slides Video

Access the full session

Session thumbnail
Ventricular tachycardia ablation outcomes

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Middle-term safety and efficacy after stereotactic arrhythmia radiotherapy: results from the prospective STARNL registry
thumbnail
Congress Session
Exploring STAR (sereotactic arrhythmia radioablation) for ventricular arrhythmia management
thumbnail
Congress Presentation
Mechanistic insights from preclinical models

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources